Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.

HR 17 Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age

Pennsylvania 2017-2018 Regular Session

Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.
HR-17


About HR-17

A Resolution requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.

  

Bill Texts

Introduced

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (16)

Votes

House Human Services: Report Bill As Committed

05/08/2017

Yeas: 16 | Nays: 0
Support by Party

   

Sponsors by party

     

Bill Sponsors

History

Laid On The Table

09/13/2018

Removed From Table

09/13/2018

Laid On The Table

05/23/2018

Removed From Table

05/23/2018

Laid On The Table

02/05/2018

Removed From Table

02/05/2018

Laid On The Table

10/26/2017

Removed From Table

10/26/2017

Laid On The Table

09/12/2017

Removed From Table

09/12/2017

Laid On The Table

06/21/2017

Removed From Table

06/21/2017

Reported As Committed

05/08/2017

Referred To Human Services

01/25/2017

Introduced As Noncontroversial Resolution Under Rule 35

01/23/2017